ABVXAbivax SA American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key: 11208
Ticker: ABVX
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2023-10-20
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ABVX

Detail

Enriched 2026-08-14 20:47

Market cap: $10,940,407,172.88
Shares outstanding (class): 87,253,797
Shares outstanding (weighted): 87,160,669
SIC: —
Employees: 69
Location: —
Homepage: https://www.abivax.com
Description: Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Market cap and share counts drift.

Funds holding this security

37 funds · 44 positions · $247.42M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$45.43M	0.42%	407,954 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$40.92M	0.50%	367,461 NS	FIGI
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST	—	$35.67M	2.25%	320,311 NS	FIGI
abrdn World Healthcare Fund —	—	$24.90M	5.18%	223,613 NS	FIGI
Invesco Main Street Mid Cap Fund AIM Growth Series (Invesco Growth Series)	—	$12.62M	0.53%	113,349 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$10.62M	0.08%	95,404 NS	FIGI
abrdn Healthcare Investors —	—	$9.87M	0.87%	88,675 NS	FIGI
Bridge Builder Tax Managed Small/Mid Cap Fund Bridge Builder Trust	—	$7.29M	0.24%	65,443 NS	FIGI
abrdn Healthcare Opportunities Fund —	—	$6.74M	0.93%	60,509 NS	FIGI
abrdn Life Sciences Investors —	—	$6.51M	1.16%	58,444 NS	FIGI
Alger Large Cap Growth Portfolio ALGER PORTFOLIOS	—	$5.09M	1.32%	45,671 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$5.01M	0.75%	45,000 NS	FIGI
Alger Capital Appreciation Portfolio ALGER PORTFOLIOS	—	$4.59M	0.70%	41,211 NS	FIGI
Mercer US Small/Mid Cap Equity Fund Mercer Funds	—	$4.42M	0.26%	39,680 NS	FIGI
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC.	—	$2.78M	0.42%	24,954 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERABVX
FIGI_COMPOSITEBBG01JLQNZ03
FIGI_SHARE_CLASSBBG01JLQNZV9
CIK0001956827
ISINUS00370M1036
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Abivax is a biotech company, so its ADRs represent equity exposure to the healthcare sector.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.